Genzyme Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genzyme stocks.

Genzyme Stocks Recent News

Date Stock Title
May 19 BMRN Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
May 18 BMRN 4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
May 17 BMRN Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
May 16 VYGR Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
May 16 BMRN Third Point top buy and sells in Q1
May 15 EXAS Most attractive short-term overwriting stocks for June expiration - Goldman
May 15 BMRN BioMarin: Short-Term Headwinds But Long-Term Opportunities Remain
May 15 BMRN Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
May 14 BMRN BioMarin Pharmaceutical to lay off 170 employees
May 14 PTCT PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts
May 14 BMRN Evercore says biotech ‘winter is finally thawing’
May 14 PTCT PTC Therapeutics wins FDA priority review for gene therapy
May 14 VYGR Q1 2024 Voyager Therapeutics Inc Earnings Call
May 14 PTCT PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™
May 14 VYGR Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript
May 14 VYGR Voyager Therapeutics Inc (VYGR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 13 VYGR Voyager Therapeutics up 8% following quarterly beats
May 13 VYGR Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
May 13 VYGR Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M
May 13 VYGR Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
Genzyme

Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.

Browse All Tags